Kehinde Idowu

ORCID: 0000-0002-1983-5927

Also affiliated with Texas Southern University

Computer SciencePharmacology, Toxicology and PharmaceuticsMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of OJT008 As a Novel Inhibitor of Mycobacterium tuberculosis”.

Characterization of OJT008 As a Novel Inhibitor of Mycobacterium tuberculosis

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.265640

N/A

0DataRank · unranked

0 citations

Collins Onyenaka, Ngan P. Ha, Edward A. Graviss, Omonike A. Olaleye, Kehinde Idowu

Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase

International Journal of Molecular Sciences(2023)10.3390/ijms242417142

N/A

0DataRank · unranked

0 citations

Kehinde Idowu, Ngan P. Ha, Edward A. Graviss, Omonike A. Olaleye, Collins Onyenaka

Molecular mechanisms underlying enhanced ACE-2-RBD stability in SARS-CoV-2 variants: The impact of key SARS-CoV-2 RBD mutations

Computational and Structural Biotechnology Reports(2025)10.1016/j.csbr.2025.100067

N/A

0DataRank · unranked

1 citations

Scott Widmann, Esther Olubunmi Olaleye, Kehinde Idowu